Biogen Inc. diskutieren
Biogen Inc.
WKN: 789617 / Symbol: BIIB / Name: Biogen / Aktie / Pharmazeutika / Large Cap /
148,00 €
-0,24 %
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $231.00 to $225.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $281.00 to $245.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank of Canada from $221.00 to $225.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $219.00 to $197.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Truist Financial Co. from $210.00 to $199.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Robert W. Baird from $300.00 to $255.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at HC Wainwright from $241.00 to $187.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Royal Bank of Canada from $217.00 to $205.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at Mizuho from $207.00 to $169.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank Of Canada from $205.00 to $213.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $187.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen Inc. (NASDAQ: BIIB) had its price target raised by analysts at Royal Bank Of Canada from $208.00 to $219.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen (NASDAQ:BIIB) had its "outperform" rating reaffirmed by analysts at William Blair.
Ratings data for BIIB provided by MarketBeat
Biogen (NASDAQ:BIIB) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $190.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen (NASDAQ:BIIB) was upgraded by analysts at Wall Street Zen from a "buy" rating to a "strong-buy" rating.
Ratings data for BIIB provided by MarketBeat
Biogen (NASDAQ:BIIB) had its price target lowered by analysts at Royal Bank Of Canada from $219.00 to $217.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen (NASDAQ:BIIB) had its price target lowered by analysts at Royal Bank Of Canada from $217.00 to $210.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen (NASDAQ:BIIB) had its price target raised by analysts at Mizuho from $169.00 to $177.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Biogen (NASDAQ:BIIB) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $202.00 price target on the stock, up previously from $144.00.
Ratings data for BIIB provided by MarketBeat
Biogen (NASDAQ:BIIB) had its price target raised by analysts at Jefferies Financial Group Inc. from $190.00 to $210.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat
Neueste Beiträge
Morgan_Stanley in Hasbro Inc. diskutieren